Cargando…

Paroxetine Increases δ Opioid Responsiveness in Sensory Neurons

There are currently no Food and Drug Administration (FDA)-approved δ-opioid receptor (DOR)-selective agonists, despite having fewer side effects in rodents and nonhuman primates compared with traditional μ-opioid receptor (MOR) therapeutics (Vanderah, 2010). Targeting peripheral receptors is an attr...

Descripción completa

Detalles Bibliográficos
Autores principales: Brackley, Allison Doyle, Jeske, Nathaniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347309/
https://www.ncbi.nlm.nih.gov/pubmed/35882549
http://dx.doi.org/10.1523/ENEURO.0063-22.2022